Matthew Thompson - 23 Dec 2022 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Director
Signature
/s/ Brad Amman as attorney-in-fact for Matthew Thompson
Issuer symbol
VVOS
Transactions as of
23 Dec 2022
Net transactions value
+$14,400
Form type
4
Filing time
28 Dec 2022, 20:45:42 UTC
Previous filing
10 Aug 2021
Next filing
28 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VVOS Stock Option (Right to Buy) Award $14,400 +30,000 +64% $0.4800 76,667 23 Dec 2022 Common Stock 76,667 $0.4800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 30,000 stock options granted on December 23, 2022. One-half vested immediately and one-eighth vests quarterly every three months through December 23, 2023.